LCMS webinars focusing on LC/HRMS - page 3

Accelerating LC/MS Impurity Screening Followed by ECD-Based Sequence Analysis for GLP-1 Analogs

Accelerating LC/MS Impurity Screening Followed by ECD-Based Sequence Analysis for GLP-1 Analogs

Episode 4 of Peptide 360 presents a staged LC/MS workflow for rapid GLP-1 impurity screening followed by ECD-based sequence analysis for precise structural confirmation and faster decisions.
RECORD
|
Already taken place Fr, 8.5.2026
Agilent Technologies
tag
share
more
Accelerating LC/MS Impurity Screening Followed by ECD-Based Sequence Analysis for GLP-1 Analogs
Integrated LC-MS CDS workflow for automated ADC and DAR analysis

Integrated LC-MS CDS workflow for automated ADC and DAR analysis

In this webinar, we’ll present an automated, high-throughput intact ADC workflow using LC-MS under native conditions on the Thermo Scientific Orbitrap Exploris 240 mass spectrometer.
RECORD
|
Already taken place We, 6.5.2026
Thermo Fisher Scientific
tag
share
more
Integrated LC-MS CDS workflow for automated ADC and DAR analysis
From Sample to Structure: Crosslinking MS Made Practical - Part 2

From Sample to Structure: Crosslinking MS Made Practical - Part 2

Crosslinking mass spectrometry (XL-MS) is transforming how researchers map protein–protein and protein–nucleic acid interactions.
RECORD
|
Already taken place Th, 30.4.2026
Thermo Fisher Scientific
tag
share
more
From Sample to Structure: Crosslinking MS Made Practical - Part 2
From Sample to Structure: Crosslinking MS Made Practical - Part 1

From Sample to Structure: Crosslinking MS Made Practical - Part 1

Crosslinking mass spectrometry (XL-MS) is transforming how researchers map protein–protein and protein–nucleic acid interactions.
RECORD
|
Already taken place Tu, 28.4.2026
Thermo Fisher Scientific
tag
share
more
From Sample to Structure: Crosslinking MS Made Practical - Part 1
Advancing and Characterizing Next-Gen Antibody Conjugates: Insights from BBB-Targeting Antibody Platforms

Advancing and Characterizing Next-Gen Antibody Conjugates: Insights from BBB-Targeting Antibody Platforms

Discover next-generation antibody therapeutics, BBB-targeting platforms, and LC-QTOF workflows for advanced characterization of complex antibody-drug and oligonucleotide conjugates.
RECORD
|
Already taken place Fr, 24.4.2026
Agilent Technologies
tag
share
more
Advancing and Characterizing Next-Gen Antibody Conjugates: Insights from BBB-Targeting Antibody Platforms
High-throughput activity based protein profiling - Systematic mapping of covalent drug-protein interactions on a proteome-wide scale

High-throughput activity based protein profiling - Systematic mapping of covalent drug-protein interactions on a proteome-wide scale

Part 3 of the Chemoproteomics Master Class highlights activity-based proteome profiling and covalent screening to accelerate target identification and drug discovery using scalable MS workflows.
RECORD
|
Already taken place Th, 23.4.2026
Thermo Fisher Scientific
tag
share
more
High-throughput activity based protein profiling - Systematic mapping of covalent drug-protein interactions on a proteome-wide scale
From experts to applications: Screening protein-drug interactions with HT-PELSA

From experts to applications: Screening protein-drug interactions with HT-PELSA

Part 2 of the Chemoproteomics Master Class explores HT-PELSA with Orbitrap Astral MS, showing peptide-level ligand binding analysis for target discovery, specificity, and drug pipeline insights.
RECORD
|
Already taken place We, 22.4.2026
Thermo Fisher Scientific
tag
share
more
From experts to applications: Screening protein-drug interactions with HT-PELSA
Mass spectrometry strategies to power drug discovery

Mass spectrometry strategies to power drug discovery

In this first master class session, explore how advanced mass spectrometry strategies are powering the next generation of drug discovery through chemoproteomics.
RECORD
|
Already taken place Tu, 21.4.2026
Thermo Fisher Scientific
tag
share
more
Mass spectrometry strategies to power drug discovery
Quantifying GLP-1 Peptides in Plasma: Bioanalytical Workflows for PK and Development

Quantifying GLP-1 Peptides in Plasma: Bioanalytical Workflows for PK and Development

Peptide 360 Episode 3 webinar on LC-MS bioanalysis of GLP-1 peptides in plasma for PK studies and development decisions.
RECORD
|
Already taken place Fr, 17.4.2026
Agilent Technologies
tag
share
more
Quantifying GLP-1 Peptides in Plasma: Bioanalytical Workflows for PK and Development
Accelerating GLP-1 Analog Impurity Profiling with the Agilent Pro IQ Plus Followed by Detailed Sequence Analysis using Electron Capture Dissociation

Accelerating GLP-1 Analog Impurity Profiling with the Agilent Pro IQ Plus Followed by Detailed Sequence Analysis using Electron Capture Dissociation

Accelerate GLP-1 impurity profiling with single quad screening and LC/Q-TOF ExD analysis. Learn how ECD improves sequence confirmation and modification localization.
RECORD
|
Already taken place Th, 16.4.2026
Agilent Technologies
tag
share
more
Accelerating GLP-1 Analog Impurity Profiling with the Agilent Pro IQ Plus Followed by Detailed Sequence Analysis using Electron Capture Dissociation
 

Related content

How Bitter Acid Analysis Helps Brewers Better Control Beer Flavors

How Bitter Acid Analysis Helps Brewers Better Control Beer Flavors

Tu, 30.6.2026
Thermo Fisher Scientific
Interlaboratory comparisons other than proficiency testing

Interlaboratory comparisons other than proficiency testing

Tu, 30.6.2026
Eurachem
Webinars LabRulezLCMS Week 27/2026

Webinars LabRulezLCMS Week 27/2026

Mo, 29.6.2026
LabRulez
‌
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike